152 related articles for article (PubMed ID: 35445504)
1. Extracorporeal photopheresis for systemic sclerosis: A meta-analysis of randomized clinical trials.
Delbrück C; Gambichler T; Susok L; Peinemann F
Dermatol Ther; 2022 Jul; 35(7):e15530. PubMed ID: 35445504
[TBL] [Abstract][Full Text] [Related]
2. Photopheresis: Advances and Use in Systemic Sclerosis.
Zhou XA; Choi J
Curr Rheumatol Rep; 2017 Jun; 19(6):31. PubMed ID: 28466383
[TBL] [Abstract][Full Text] [Related]
3. Incidence of lung cancer in patients with systemic sclerosis treated with extracorporeal photopheresis.
Topuzoglu S; Knobler R; Movadat O; Petkov V; Foedinger D; Just U; Pehamberger H; Jantschitsch C
Photodermatol Photoimmunol Photomed; 2015 Jul; 31(4):175-83. PubMed ID: 25495608
[TBL] [Abstract][Full Text] [Related]
4. Preliminary results on long-term follow-up of systemic sclerosis patients under extracorporeal photopheresis.
Gambichler T; Özsoy O; Bui D; Scheel CH; Susok L
J Dermatolog Treat; 2022 Jun; 33(4):1979-1982. PubMed ID: 33944664
[TBL] [Abstract][Full Text] [Related]
5. Use of Extracorporeal Photopheresis in Scleroderma: A Review.
Du AX; Osman M; Gniadecki R
Dermatology; 2020; 236(2):105-110. PubMed ID: 31362294
[TBL] [Abstract][Full Text] [Related]
6. The assessment of immune-regulatory effects of extracorporeal photopheresis in systemic sclerosis: a long-term follow-up study.
Papp G; Horvath IF; Gyimesi E; Barath S; Vegh J; Szodoray P; Zeher M
Immunol Res; 2016 Apr; 64(2):404-11. PubMed ID: 26168768
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory effects of extracorporeal photochemotherapy in systemic sclerosis.
Papp G; Horvath IF; Barath S; Gyimesi E; Vegh J; Szodoray P; Zeher M
Clin Immunol; 2012 Feb; 142(2):150-9. PubMed ID: 22036269
[TBL] [Abstract][Full Text] [Related]
8. Management of severe scleroderma with long-term extracorporeal photopheresis.
Krasagakis K; Dippel E; Ramaker J; Owsianowski M; Orfanos CE
Dermatology; 1998; 196(3):309-15. PubMed ID: 9621138
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group.
McKenna KE; Whittaker S; Rhodes LE; Taylor P; Lloyd J; Ibbotson S; Russell-Jones R; ;
Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088
[TBL] [Abstract][Full Text] [Related]
10. The effects of extracorporeal photochemotherapy on T cell activation and regulatory mechanisms in patients with systemic sclerosis.
Papp G; Barath S; Szegedi A; Szodoray P; Zeher M
Clin Rheumatol; 2012 Sep; 31(9):1293-9. PubMed ID: 22706443
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
Weitz M; Strahm B; Meerpohl JJ; Bassler D
Cochrane Database Syst Rev; 2014 Feb; (2):CD009898. PubMed ID: 24569961
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis.
Knobler RM; French LE; Kim Y; Bisaccia E; Graninger W; Nahavandi H; Strobl FJ; Keystone E; Mehlmauer M; Rook AH; Braverman I;
J Am Acad Dermatol; 2006 May; 54(5):793-9. PubMed ID: 16635659
[TBL] [Abstract][Full Text] [Related]
13. Interventions for mycosis fungoides.
Weberschock T; Strametz R; Lorenz M; Röllig C; Bunch C; Bauer A; Schmitt J
Cochrane Database Syst Rev; 2012 Sep; (9):CD008946. PubMed ID: 22972128
[TBL] [Abstract][Full Text] [Related]
14. The North American experience with photopheresis.
Zic JA; Miller JL; Stricklin GP; King LE
Ther Apher; 1999 Feb; 3(1):50-62. PubMed ID: 10079806
[TBL] [Abstract][Full Text] [Related]
15. Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
Weitz M; Strahm B; Meerpohl JJ; Bassler D
Cochrane Database Syst Rev; 2014 Feb; (2):CD009759. PubMed ID: 24569960
[TBL] [Abstract][Full Text] [Related]
16. Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis).
Enomoto DN; Mekkes JR; Bossuyt PM; Yong SL; Out TA; Hoekzema R; de Rie MA; Schellekens PT; ten Berge IJ; de Borgie CA; Bos JD
J Am Acad Dermatol; 1999 Dec; 41(6):915-22. PubMed ID: 10570373
[TBL] [Abstract][Full Text] [Related]
17. Photodegradation of folic acid during extracorporeal photopheresis.
Der-Petrossian M; Födinger M; Knobler R; Hönigsmann H; Trautinger F
Br J Dermatol; 2007 Jan; 156(1):117-21. PubMed ID: 17199577
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal photopheresis as a therapy for autoimmune diseases.
Kuzmina Z; Stroncek D; Pavletic SZ
J Clin Apher; 2015 Aug; 30(4):224-37. PubMed ID: 25546289
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal photoimmunotherapy-photopheresis.
Dani T; Knobler R
Front Biosci (Landmark Ed); 2009 Jan; 14(12):4769-77. PubMed ID: 19273388
[TBL] [Abstract][Full Text] [Related]
20. Impact of extracorporeal photopheresis on blood and coagulation parameters.
Gambichler T; Chatzipantazi M; Stranzenbach R; Feldkamp A; Susok L
Dermatol Ther; 2022 May; 35(5):e15366. PubMed ID: 35141988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
